Matches in SemOpenAlex for { <https://semopenalex.org/work/W2017665309> ?p ?o ?g. }
- W2017665309 endingPage "15935" @default.
- W2017665309 startingPage "15930" @default.
- W2017665309 abstract "P-glycoprotein, an ATP-driven drug efflux pump, is a major obstacle to the delivery of small-molecule drugs across the blood-brain barrier and into the CNS. Here we test a unique signaling-based strategy to overcome this obstacle. We used a confocal microscopy-based assay with isolated rat brain capillaries to map a signaling pathway that within minutes abolishes P-glycoprotein transport activity without altering transporter protein expression or tight junction permeability. This pathway encompasses elements of proinflammatory- (TNF-α) and sphingolipid-based signaling. Critical to this pathway was signaling through sphingosine-1-phosphate receptor 1 (S1PR1). In brain capillaries, S1P acted through S1PR1 to rapidly and reversibly reduce P-glycoprotein transport activity. Sphingosine reduced transport by a sphingosine kinase-dependent mechanism. Importantly, fingolimod (FTY720), a S1P analog recently approved for treatment of multiple sclerosis, also rapidly reduced P-glycoprotein activity; similar effects were found with the active, phosphorylated metabolite (FTY720P). We validated these findings in vivo using in situ brain perfusion in rats. Administration of S1P, FTY720, or FTY729P increased brain uptake of three radiolabeled P-glycoprotein substrates, 3 H-verapamil (threefold increase), 3 H-loperamide (fivefold increase), and 3 H-paclitaxel (fivefold increase); blocking S1PR1 abolished this effect. Tight junctional permeability, measured as brain 14 C-sucrose accumulation, was not altered. Therefore, targeting signaling through S1PR1 at the blood-brain barrier with the sphingolipid-based drugs, FTY720 or FTY720P, can rapidly and reversibly reduce basal P-glycoprotein activity and thus improve delivery of small-molecule therapeutics to the brain." @default.
- W2017665309 created "2016-06-24" @default.
- W2017665309 creator A5011194642 @default.
- W2017665309 creator A5038645201 @default.
- W2017665309 creator A5039791842 @default.
- W2017665309 creator A5064965438 @default.
- W2017665309 creator A5079182166 @default.
- W2017665309 date "2012-09-04" @default.
- W2017665309 modified "2023-10-16" @default.
- W2017665309 title "Targeting blood-brain barrier sphingolipid signaling reduces basal P-glycoprotein activity and improves drug delivery to the brain" @default.
- W2017665309 cites W1499705597 @default.
- W2017665309 cites W176733150 @default.
- W2017665309 cites W1973522717 @default.
- W2017665309 cites W1974572321 @default.
- W2017665309 cites W1975242896 @default.
- W2017665309 cites W1977066256 @default.
- W2017665309 cites W1981686290 @default.
- W2017665309 cites W1982164176 @default.
- W2017665309 cites W1982452078 @default.
- W2017665309 cites W2011914090 @default.
- W2017665309 cites W2013908566 @default.
- W2017665309 cites W2013989011 @default.
- W2017665309 cites W2023933550 @default.
- W2017665309 cites W2024679475 @default.
- W2017665309 cites W2043773337 @default.
- W2017665309 cites W2051017409 @default.
- W2017665309 cites W2073392285 @default.
- W2017665309 cites W2076738925 @default.
- W2017665309 cites W2078067317 @default.
- W2017665309 cites W2078068647 @default.
- W2017665309 cites W2088955402 @default.
- W2017665309 cites W2091969269 @default.
- W2017665309 cites W2093366614 @default.
- W2017665309 cites W2102478723 @default.
- W2017665309 cites W2108486409 @default.
- W2017665309 cites W2108641213 @default.
- W2017665309 cites W2117904740 @default.
- W2017665309 cites W2124224297 @default.
- W2017665309 cites W2125748363 @default.
- W2017665309 cites W2127141798 @default.
- W2017665309 cites W2127993357 @default.
- W2017665309 cites W2130193551 @default.
- W2017665309 cites W2140975778 @default.
- W2017665309 cites W2141995611 @default.
- W2017665309 cites W2145099250 @default.
- W2017665309 cites W2149021083 @default.
- W2017665309 cites W2149441416 @default.
- W2017665309 cites W2153331027 @default.
- W2017665309 cites W2159821105 @default.
- W2017665309 cites W2160209245 @default.
- W2017665309 cites W2161269202 @default.
- W2017665309 cites W2169486789 @default.
- W2017665309 cites W4232733723 @default.
- W2017665309 cites W4237311797 @default.
- W2017665309 doi "https://doi.org/10.1073/pnas.1203534109" @default.
- W2017665309 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3465435" @default.
- W2017665309 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22949658" @default.
- W2017665309 hasPublicationYear "2012" @default.
- W2017665309 type Work @default.
- W2017665309 sameAs 2017665309 @default.
- W2017665309 citedByCount "118" @default.
- W2017665309 countsByYear W20176653092012 @default.
- W2017665309 countsByYear W20176653092013 @default.
- W2017665309 countsByYear W20176653092014 @default.
- W2017665309 countsByYear W20176653092015 @default.
- W2017665309 countsByYear W20176653092016 @default.
- W2017665309 countsByYear W20176653092017 @default.
- W2017665309 countsByYear W20176653092018 @default.
- W2017665309 countsByYear W20176653092019 @default.
- W2017665309 countsByYear W20176653092020 @default.
- W2017665309 countsByYear W20176653092021 @default.
- W2017665309 countsByYear W20176653092022 @default.
- W2017665309 countsByYear W20176653092023 @default.
- W2017665309 crossrefType "journal-article" @default.
- W2017665309 hasAuthorship W2017665309A5011194642 @default.
- W2017665309 hasAuthorship W2017665309A5038645201 @default.
- W2017665309 hasAuthorship W2017665309A5039791842 @default.
- W2017665309 hasAuthorship W2017665309A5064965438 @default.
- W2017665309 hasAuthorship W2017665309A5079182166 @default.
- W2017665309 hasBestOaLocation W20176653091 @default.
- W2017665309 hasConcept C133936738 @default.
- W2017665309 hasConcept C134018914 @default.
- W2017665309 hasConcept C140800825 @default.
- W2017665309 hasConcept C146285616 @default.
- W2017665309 hasConcept C167734588 @default.
- W2017665309 hasConcept C170493617 @default.
- W2017665309 hasConcept C185592680 @default.
- W2017665309 hasConcept C2776596873 @default.
- W2017665309 hasConcept C2777025900 @default.
- W2017665309 hasConcept C2778402981 @default.
- W2017665309 hasConcept C2778703144 @default.
- W2017665309 hasConcept C2778707650 @default.
- W2017665309 hasConcept C501593827 @default.
- W2017665309 hasConcept C502942594 @default.
- W2017665309 hasConcept C529278444 @default.
- W2017665309 hasConcept C55493867 @default.
- W2017665309 hasConcept C61705674 @default.
- W2017665309 hasConcept C86803240 @default.